Methods of treating symptoms of coronavirus infection with RNA polymerase inhibitors
US12274700B1 · kind B1 · utility
0Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 2021 |
| Grant date | Apr 15, 2025 |
| Priority date | — |
| Expiry date | Nov 1, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating or alleviating at least one symptom of a coronavirus infection in a subject, by administering to the subject a therapeutically effective amount of an RNA polymerase inhibitor. In some embodiments, the symptom is selected from the group consisting of fever, cough, tiredness, sore throat, diarrhea, conjunctivitis, headache, loss of taste, loss of smell, rash, difficulty breathing, shortness of breath, chest pain, chest pressure, Acute Respiratory Distress Syndrome (ARDS) and organ failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.